CD163 and neoplasm: To confirm the results obtained by comprehensive bioinformatics analysis, we performed immunohistochemical staining of tumor tissues from 80 patients with PTC and 18 patients with ATC for the M2 macrophage marker CD163 and the Treg marker Foxp3.